• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    PROPOSAL
    Maryland Register
    Issue Date:  December 9, 2016
    Volume 43 • Issue 25• Pages 1398—1401
     
    Title 10
    DEPARTMENT OF HEALTH AND MENTAL HYGIENE
    Subtitle 09 MEDICAL CARE PROGRAMS
    10.09.70 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services
    Authority: Health-General Article, §§2-104(b), 15-103, and 15-105, Annotated Code of Maryland
    Notice of Proposed Action
    [16-326-P]
    The Secretary of Health and Mental Hygiene proposes to amend Regulation .02 under COMAR 10.09.70 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services.
    Statement of Purpose
    The purpose of this action is to update the ICD-10 diagnosis codes included in the behavioral health carve out. The amendment delineates which claims the Administrative Service Organization is responsible for paying and which claims the Managed Care Organizations are responsible for paying. This will bring the regulations up to date with the latest CMS mandated updates.
    Comparison to Federal Standards
    There is no corresponding federal standard to this proposed action.
    Estimate of Economic Impact
    The proposed action has no economic impact.
    Economic Impact on Small Businesses
    The proposed action has minimal or no economic impact on small businesses.
    Impact on Individuals with Disabilities
    The proposed action has no impact on individuals with disabilities.
    Opportunity for Public Comment
    Comments may be sent to Michele Phinney, Director, Office of Regulation and Policy Coordination, Department of Health and Mental Hygiene, 201 West Preston Street, Room 512, Baltimore, MD 21201, or call 410-767-6499 (TTY 800-735-2258), or email to dhmh.regs@maryland.gov, or fax to 410-767-6483. Comments will be accepted through January 9, 2017. A public hearing has not been scheduled.
    .02 Behavioral Health Non-Capitated Covered Services.
    A.—C. (text unchanged)
    D. An MCO is not responsible for reimbursing for the following substance use disorder services if the MCO is billed with a primary diagnosis listed in [§J] §K of this regulation:
    E.—F. (text unchanged)
    G. An MCO is not responsible for reimbursing the behavioral poisoning diagnoses listed in §N of this regulation in an emergency department setting.
    [G.] H. An MCO is not responsible for services billed by specialty mental health providers listed in COMAR 10.09.59 when the bill includes the specialty behavioral health diagnoses listed in [§J or K] §K or L in the primary diagnosis field.
    [H.] I.[J.] K. (text unchanged)
    [K.] L. Table of mental health diagnoses:
    (1) (text unchanged)
     (2) For dates of service on or after October 1, 2015:
     
    F200—F325
    (text unchanged)
    [F328
    Other depressive episodes]
    F3281
    Premenstrual dysphoric disorder
    F3289
    Other specified depressive episodes
    F329—F341
    (text unchanged)
    [F348
    Other persistent mood (affective) disorders]
    F3481
    Disruptive mood dysregulation disorder
    F3489
    Other specified persistent mood disorders
    F349—F419
    (text unchanged)
    [F42
    Obsessive-compulsive disorder]
    F422
    Mixed obsessional thoughts and acts
    F423
    Hoarding disorder
    F424
    Excoriation (skin-picking) disorder
    F428
    Other obsessive compulsive disorder
    F429
    Obsessive-compulsive disorder, unspecified
    F430—F502
    (text unchanged)
    [F508
    Other eating disorders]
    F5081
    Binge eating disorder
    F5089
    Other specified eating disorder
    F509—F639
    (text unchanged)
    F640
    Transsexualism
    F641—Z046
    (text unchanged)
     
    [L.] M. (text unchanged)
    N. Table of poisoning diagnoses, for dates of service on or after July 1, 2016:
     
    T360X2A
    Poisoning by penicillins, intentional self-harm
    T361X2A
    Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm
    T362X2A
    Poisoning by chloramphenicol group, intentional self-harm
    Poisoning by macrolides, intentional self-harm
    T364X2A
    Poisoning by tetracyclines, intentional self-harm
    T365X2A
    Poisoning by aminoglycosides, intentional self-harm
    T366X2A
    Poisoning by rifampicins, intentional self-harm
    T367X2A
    Poisoning by antifungal antibiotics, systemically used, intentional self-harm
    T368X2A
    Poisoning by other systemic antibiotics, intentional self-harm
    T369X2A
    Poisoning by unspecified systemic antibiotic, intentional self-harm
    T370X2A
    Poisoning by sulfonamides, intentional self-harm
    T371X2A
    Poisoning by antimycobacterial drugs, intentional self-harm
    T372X2A
    Poisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm
    T373X2A
    Poisoning by other antiprotozoal drugs, intentional self-harm
    T374X2A
    Poisoning by anthelminthics, intentional self-harm
    T375X2A
    Poisoning by antiviral drugs, intentional self-harm
    T378X2A
    Poisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm
    T3792XA
    Poisoning by unspecified systemic anti-infective and antiparasitics, intentional self-harm
    T380X2A
    Poisoning by glucocorticoids and synthetic analogues, intentional self-harm
    T381X2A
    Poisoning by thyroid hormones and substitutes, intentional self-harm
    T382X2A
    Poisoning by antithyroid drugs, intentional self-harm
    T383X2A
    Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm
    T384X2A
    Poisoning by oral contraceptives, intentional self-harm
    T385X2A
    Poisoning by other estrogens and progestogens, intentional self-harm
    T386X2A
    Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm
    T387X2A
    Poisoning by androgens and anabolic congeners, intentional self-harm
    T38802A
    Poisoning by unspecified hormones and synthetic substitutes, intentional self-harm
    T38812A
    Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm
    T38892A
    Poisoning by other hormones and synthetic substitutes, intentional self-harm
    T38902A
    Poisoning by unspecified hormone antagonists, intentional self-harm
    T38992A
    Poisoning by other hormone antagonists, intentional self-harm
    T39012A
    Poisoning by aspirin, intentional self-harm
    T39092A
    Poisoning by salicylates, intentional self-harm
    T391X2A
    Poisoning by 4-Aminophenol derivatives, intentional self-harm
    T392X2A
    Poisoning by pyrazolone derivatives, intentional self-harm
    T39312A
    Poisoning by propionic acid derivatives, intentional self-harm
    T39392A
    Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm
    T394X2A
    Poisoning by antirheumatics, not elsewhere classified, intentional self-harm
    T398X2A
    Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm
    T3992XA
    Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm
    T400X2A
    Poisoning by opium, intentional self-harm
    T401X2A
    Poisoning by heroin, intentional self-harm
    T402X2A
    Poisoning by other opioids, intentional self-harm
    T403X2A
    Poisoning by methadone, intentional self-harm
    T404X2A
    Poisoning by other synthetic narcotics, intentional self-harm
    T405X2A
    Poisoning by cocaine, intentional self-harm
    T40602A
    Poisoning by unspecified narcotics, intentional self-harm
    T40692A
    Poisoning by other narcotics, intentional self-harm
    T407X2A
    Poisoning by cannabis (derivatives), intentional self-harm
    T408X2A
    Poisoning by lysergide [LSD], intentional self-harm
    T40902A
    Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm
    Poisoning by other psychodysleptics [hallucinogens], intentional self-harm
    T410X2A
    Poisoning by inhaled anesthetics, intentional self-harm
    T411X2A
    Poisoning by intravenous anesthetics, intentional self-harm
    T41202A
    Poisoning by unspecified general anesthetics, intentional self-harm
    T41292A
    Poisoning by other general anesthetics, intentional self-harm
    T413X2A
    Poisoning by local anesthetics, intentional self-harm
    T4142XA
    Poisoning by unspecified anesthetic, intentional self-harm
    T415X2A
    Poisoning by therapeutic gases, intentional self-harm
    T420X2A
    Poisoning by hydantoin derivatives, intentional self-harm
    T421X2A
    Poisoning by iminostilbenes, intentional self-harm
    T422X2A
    Poisoning by succinimides and oxazolidinediones, intentional self-harm
    T423X2A
    Poisoning by barbiturates, intentional self-harm
    T424X2A
    Poisoning by benzodiazepines, intentional self-harm
    T425X2A
    Poisoning by mixed antiepileptics, intentional self-harm
    T426X2A
    Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm
    T4272XA
    Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm
    T428X2A
    Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm
    T43012A
    Poisoning by tricyclic antidepressants, intentional self-harm
    T43022A
    Poisoning by tetracyclic antidepressants, intentional self-harm
    T431X2A
    Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm
    T43202A
    Poisoning by unspecified antidepressants, intentional self-harm
    T43212A
    Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm
    T43222A
    Poisoning by selective serotonin reuptake inhibitors, intentional self-harm
    T43292A
    Poisoning by other antidepressants, intentional self-harm
    T433X2A
    Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm
    T434X2A
    Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm
    T43502A
    Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm
    T43592A
    Poisoning by other antipsychotics and neuroleptics, intentional self-harm
    T43602A
    Poisoning by unspecified psychostimulants, intentional self-harm
    T43612A
    Poisoning by caffeine, intentional self-harm
    T43622A
    Poisoning by amphetamines, intentional self-harm
    T43632A
    Poisoning by methylphenidate, intentional self-harm
    T43692A
    Poisoning by other psychostimulants, intentional self-harm
    T438X2A
    Poisoning by other psychotropic drugs, intentional self-harm
    T4392XA
    Poisoning by unspecified psychotropic drug, intentional self-harm
    T440X2A
    Poisoning by anticholinesterase agents, intentional self-harm
    T441X2A
    Poisoning by other parasympathomimetics [cholinergics], intentional self-harm
    T442X2A
    Poisoning by ganglionic blocking drugs, intentional self-harm
    T443X2A
    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm
    T444X2A
    Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm
    T445X2A
    Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm
    T446X2A
    Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm
    T447X2A
    Poisoning by beta-adrenoreceptor antagonists, intentional self-harm
    T448X2A
    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm
    T44902A
    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm
    T44992A
    Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm
    T450X2A
    Poisoning by antiallergic and antiemetic drugs, intentional self-harm
    T451X2A
    Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm
    T452X2A
    Poisoning by vitamins, intentional self-harm
    T453X2A
    Poisoning by enzymes, intentional self-harm
    T454X2A
    Poisoning by iron and its compounds, intentional self-harm
    T45512A
    Poisoning by anticoagulants, intentional self-harm
    T45522A
    Poisoning by antithrombotic drugs, intentional self-harm
    T45602A
    Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm
    T45612A
    Poisoning by thrombolytic drug, intentional self-harm
    T45622A
    Poisoning by hemostatic drug, intentional self-harm
    T45692A
    Poisoning by other fibrinolysis-affecting drugs, intentional self-harm
    T457X2A
    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm
    T458X2A
    Poisoning by other primarily systemic and hematological agents, intentional self-harm
    T4592XA
    Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm
    T460X2A
    Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
    T461X2A
    Poisoning by calcium-channel blockers, intentional self-harm
    T462X2A
    Poisoning by other antidysrhythmic drugs, intentional self-harm
    T463X2A
    Poisoning by coronary vasodilators, intentional self-harm
    T464X2A
    Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
    T465X2A
    Poisoning by other antihypertensive drugs, intentional self-harm
    T466X2A
    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
    T467X2A
    Poisoning by peripheral vasodilators, intentional self-harm
    T468X2A
    Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
    T46902A
    Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
    T46992A
    Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
    T470X2A
    Poisoning by histamine H2-receptor blockers, intentional self-harm
    T471X2A
    Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm
    T472X2A
    Poisoning by stimulant laxatives, intentional self-harm
    T473X2A
    Poisoning by saline and osmotic laxatives, intentional self-harm
    T474X2A
    Poisoning by other laxatives, intentional self-harm
    T475X2A
    Poisoning by digestants, intentional self-harm
    T476X2A
    Poisoning by antidiarrheal drugs, intentional self-harm
    T477X2A
    Poisoning by emetics, intentional self-harm
    T478X2A
    Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm
    T4792XA
    Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm
    T480X2A
    Poisoning by oxytocic drugs, intentional self-harm
    T481X2A
    Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm
    T48202A
    Poisoning by unspecified drugs acting on muscles, intentional self-harm
    T48292A
    Poisoning by other drugs acting on muscles, intentional self-harm
    T483X2A
    Poisoning by antitussives, intentional self-harm
    T484X2A
    Poisoning by expectorants, intentional self-harm
    T485X2A
    Poisoning by other anti-common-cold drugs, intentional self-harm
    T486X2A
    Poisoning by antiasthmatics, intentional self-harm
    T48902A
    Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm
    T48992A
    Poisoning by other agents primarily acting on the respiratory system, intentional self-harm
    T490X2A
    Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm
    T491X2A
    Poisoning by antipruritics, intentional self-harm
    T492X2A
    Poisoning by local astringents and local detergents, intentional self-harm
    T493X2A
    Poisoning by emollients, demulcents and protectants, intentional self-harm
    T494X2A
    Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm
    T495X2A
    Poisoning by ophthalmological drugs and preparations, intentional self-harm
    T496X2A
    Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm
    T497X2A
    Poisoning by dental drugs, topically applied, intentional self-harm
    T498X2A
    Poisoning by other topical agents, intentional self-harm
    T4992XA
    Poisoning by unspecified topical agent, intentional self-harm
    T500X2A
    Poisoning by mineralocorticoids and their antagonists, intentional self-harm
    T501X2A
    Poisoning by loop [high-ceiling] diuretics, intentional self-harm
    T502X2A
    Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm
    T503X2A
    Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm
    T504X2A
    Poisoning by drugs affecting uric acid metabolism, intentional self-harm
    T505X2A
    Poisoning by appetite depressants, intentional self-harm
    T506X2A
    Poisoning by antidotes and chelating agents, intentional self-harm
    T507X2A
    Poisoning by analeptics and opioid receptor antagonists, intentional self-harm
    T508X2A
    Poisoning by diagnostic agents, intentional self-harm
    T50902A
    Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm
    T50992A
    Poisoning by other drugs, medicaments and biological substances, intentional self-harm
    VAN T. MITCHELL
    Secretary of Health and Mental Hygiene